Comparison of a mycobacterial phage assay to detect viable Mycobacterium avium subspecies paratuberculosis with standard diagnostic modalities in cattle with naturally infected Johne disease.
Crohn disease
Johne disease
Mycobacteriophage
Mycobacterium avium subspecies paratuberculosis (MAP)
Peripheral blood mononuclear cells (PBMCs)
Phage assay
Quantitative PCR
Journal
Gut pathogens
ISSN: 1757-4749
Titre abrégé: Gut Pathog
Pays: England
ID NLM: 101474263
Informations de publication
Date de publication:
06 May 2021
06 May 2021
Historique:
received:
01
10
2020
accepted:
29
04
2021
entrez:
7
5
2021
pubmed:
8
5
2021
medline:
8
5
2021
Statut:
epublish
Résumé
Mycobacterium avium subspecies paratuberculosis (MAP), the cause of Johne disease, is a slow growing mycobacterium. Viable MAP detection is difficult, inconstant and time-consuming. The purpose of this study was to compare a rapid phage/qPCR assay performed on peripheral blood mononuclear cells (PBMCs) with three standard methods of MAP detection: fecal MAP PCR; plasma antigen-specific IFN-γ & serum MAP ELISA hypothesizing that, if sensitive and specific, Johne animals would be positive and Control animals negative. We studied a well characterized herd of Holstein cattle that were naturally infected with MAP and their Controls. With phage/qPCR 72% (23/32) of Johne and 35% (6/17) of Controls were MAP positive. With fecal PCR 75% (24/32) of Johne and 0% (0/17) of Controls were MAP positive. With plasma antigen-specific IFN-γ 69% (22/32) of Johne and 12% (2/17) of Controls were MAP positive. With serum MAP ELISA, 31% (10/32) of Johne and 0% (0/17) of Controls were MAP positive. When phage / qPCR and fecal PCR results were combined, 100% (32/32) Johne and 35% (6/17) of Control animals were MAP positive. Younger Control animals (1-3 years) had significantly fewer plaques (25 ± 17 SEM) than older Controls (4-12 years) (309 ± 134 p = 0.04). The same trend was not observed in the Johne animals (p = 0.19). In contrast to our hypothesis, using the phage/qPCR assay we find that viable circulating MAP can rapidly be detected from the blood of animals infected with, as well as those in the Control group evidently colonized by MAP. These data indicate that the presence of viable MAP in blood does not necessarily signify that an animal must of necessity be demonstrably ill or be MAP positive by standard diagnostic methods.
Sections du résumé
BACKGROUND
BACKGROUND
Mycobacterium avium subspecies paratuberculosis (MAP), the cause of Johne disease, is a slow growing mycobacterium. Viable MAP detection is difficult, inconstant and time-consuming. The purpose of this study was to compare a rapid phage/qPCR assay performed on peripheral blood mononuclear cells (PBMCs) with three standard methods of MAP detection: fecal MAP PCR; plasma antigen-specific IFN-γ & serum MAP ELISA hypothesizing that, if sensitive and specific, Johne animals would be positive and Control animals negative. We studied a well characterized herd of Holstein cattle that were naturally infected with MAP and their Controls.
RESULTS
RESULTS
With phage/qPCR 72% (23/32) of Johne and 35% (6/17) of Controls were MAP positive. With fecal PCR 75% (24/32) of Johne and 0% (0/17) of Controls were MAP positive. With plasma antigen-specific IFN-γ 69% (22/32) of Johne and 12% (2/17) of Controls were MAP positive. With serum MAP ELISA, 31% (10/32) of Johne and 0% (0/17) of Controls were MAP positive. When phage / qPCR and fecal PCR results were combined, 100% (32/32) Johne and 35% (6/17) of Control animals were MAP positive. Younger Control animals (1-3 years) had significantly fewer plaques (25 ± 17 SEM) than older Controls (4-12 years) (309 ± 134 p = 0.04). The same trend was not observed in the Johne animals (p = 0.19).
CONCLUSIONS
CONCLUSIONS
In contrast to our hypothesis, using the phage/qPCR assay we find that viable circulating MAP can rapidly be detected from the blood of animals infected with, as well as those in the Control group evidently colonized by MAP. These data indicate that the presence of viable MAP in blood does not necessarily signify that an animal must of necessity be demonstrably ill or be MAP positive by standard diagnostic methods.
Identifiants
pubmed: 33957980
doi: 10.1186/s13099-021-00425-5
pii: 10.1186/s13099-021-00425-5
pmc: PMC8103604
doi:
Types de publication
Journal Article
Langues
eng
Pagination
30Références
Gut Pathog. 2013 Jun 13;5:14
pubmed: 23759115
Vet Rec. 2013 Nov 30;173(21):522-3
pubmed: 24293440
Aust Vet J. 2012 Apr;90(4):116-21
pubmed: 22443325
Scand J Gastroenterol. 2018 Apr;53(4):505
pubmed: 29447017
BMC Vet Res. 2019 Jun 13;15(1):198
pubmed: 31196162
Lancet Infect Dis. 2003 Aug;3(8):507-14
pubmed: 12901893
Prev Vet Med. 2009 Oct 1;91(2-4):189-96
pubmed: 19525022
J Clin Microbiol. 2011 May;49(5):2017-9
pubmed: 21411581
Rev Sci Tech. 2001 Apr;20(1):151-79
pubmed: 11288510
Vet Microbiol. 2009 Mar 2;134(3-4):346-52
pubmed: 18926647
Lepr Rev. 1962 Apr;33:119-28
pubmed: 14492126
Lancet. 2004 Apr 10;363(9416):1209-19
pubmed: 15081655
J Vet Diagn Invest. 1997 Oct;9(4):375-80
pubmed: 9376426
Lepr Rev. 1997 Dec;68(4):301-15
pubmed: 9503866
Microorganisms. 2020 Aug 20;8(9):
pubmed: 32825389
Aust Vet J. 2005 Jul;83(7):435-41
pubmed: 16035186
Microorganisms. 2020 Dec 21;8(12):
pubmed: 33371478
Appl Environ Microbiol. 2009 Jun;75(12):3896-902
pubmed: 19395561
Comp Immunol Microbiol Infect Dis. 2010 Sep;33(5):389-400
pubmed: 19345998
BMC Vet Res. 2016 Jun 16;12(1):115
pubmed: 27305900
J Med Assoc Thai. 2007 Jun;90(6):1188-92
pubmed: 17624216
Inflamm Bowel Dis. 2008 Aug;14(8):1170-2
pubmed: 18340644
J Clin Microbiol. 1984 Nov;20(5):966-71
pubmed: 6511878
Comp Immunol Microbiol Infect Dis. 2011 May;34(3):197-208
pubmed: 21216466
Future Microbiol. 2019 May;14:643-646
pubmed: 31148467
Infect Immun. 2019 Dec 17;88(1):
pubmed: 31611273
Autoimmune Dis. 2010 Jun 20;2011:127692
pubmed: 21152214
Dig Dis Sci. 2017 Jan;62(1):282-283
pubmed: 27812848
N Engl J Med. 1998 Mar 5;338(10):640-4
pubmed: 9486992
J Microbiol Methods. 2013 Sep;94(3):175-9
pubmed: 23811207
Vet Immunol Immunopathol. 2020 Jul;225:110060
pubmed: 32413513
Vet Microbiol. 2007 Jun 21;122(3-4):197-222
pubmed: 17467201
BMC Infect Dis. 2012 Apr 14;12:91
pubmed: 22502597
Am J Public Health Nations Health. 1954 Oct;44(10):1326-33
pubmed: 13197609
Lancet. 2004 Jul 31-Aug 6;364(9432):396-7
pubmed: 15288721
J Infect. 2003 May;46(4):215-20
pubmed: 12799146
Can J Microbiol. 2011 May;57(5):347-54
pubmed: 21510779
Foodborne Pathog Dis. 2015 Sep;12(9):812
pubmed: 26110358
J Appl Microbiol. 2017 May;122(5):1357-1367
pubmed: 28235155
J Crohns Colitis. 2014 Oct;8(10):1334-5
pubmed: 24768214
Front Neurol. 2019 Feb 19;10:122
pubmed: 30837941
Eur Respir J. 2019 Sep 12;54(3):
pubmed: 31221810
Inflamm Bowel Dis. 2019 Apr 11;25(5):e48
pubmed: 30295733